Trial intelligence / Profile preview

Landiolol for perioperative tachyarrhythmias in general anesthesia

CTR20243740Phase 3Completed

Sponsor
Hainan Herui Pharmaceutical
Start
Oct 2024
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of landiolol in Atrial fibrillation (AFib), atrial flutter (AFL), sinus tachycardia (ST), tachyarrhythmia, sponsored by Hainan Herui Pharmaceutical. Started Oct 2024; status: completed.

02

Drugs

landiolol
03

Conditions

Atrial fibrillation (AFib)atrial flutter (AFL)sinus tachycardia (ST)tachyarrhythmia

Beyond the preview

Go deeper on CTR20243740.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20243740.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call